One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire

By Lukacs B.   Grange J.C.   Comet D.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 540-546

Elsevier

Access to resources Recommend Favorite

Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction

By Marklund-Bau Helén   Edéll-Gustafsson Ulla   Spångberg Anders  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 1, 2007-01 ,pp. : 32-41

Informa Healthcare

Access to resources Recommend Favorite

Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Eckhardt M.D.   van Venrooij G.E.P.M.   Boon T.A.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 695-700

Elsevier

Access to resources Recommend Favorite

Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Masumori Naoya   Hashimoto Jiro   Itoh Naoki   Tsukamoto Taiji   Group The Sapporo Medical University Naftopidil Study  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 5, 2007-01 ,pp. : 422-429

Informa Healthcare

Access to resources Recommend Favorite

Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care-The Triumph Project

By Verhamme K.M.C.   Dieleman J.P.   Bleumink G.S.   van der Lei J.   Sturkenboom M.C.J.M.   Triumph Pan European Expert Panel  

European Urology, Vol. 42, Iss. 4, 2002-10 ,pp. : 323-328

Elsevier

Access to resources Recommend Favorite